MAT continuity commonly breaks during inpatient stays and at discharge. The failure is rarely clinical intentâit is operational: unclear prescribing ownership, pharmacy delays, missing bridge supplies, and âfollow up with your clinicâ discharge notes that do not create a real appointment or a verifiable handoff. Counties that treat hospital discharge as a controlled medication-transition workflow can reduce relapse risk, prevent avoidable ED returns, and improve system defensibility. This approach aligns with MAT access pathway resources and the broader operating model in community-based SUD service model guidance, focusing on day-to-day handoff mechanics that withstand oversight.
Where hospital discharge pathways fail
Common breakdowns include: inpatient teams stopping or under-dosing MAT due to uncertainty; discharge prescriptions written without confirming pharmacy stock or prior authorization; no defined plan for weekend/holiday discharge; and referrals sent without confirmation that the receiving provider can see the person within a clinically safe window. The highest-risk failure mode is a short, unplanned gap that triggers withdrawal, relapse, or polysubstance useâfollowed by ED return, overdose risk, or unplanned readmission.
Oversight expectations that shape discharge design
Expectation 1: Medication reconciliation and continuity evidence. Funders, accrediting bodies, and hospital governance teams expect auditable medication reconciliation and a documented continuity plan for high-risk medications, including MAT, with named responsible roles and time-bound actions.
Expectation 2: Safe, coordinated transitions of care. Oversight expects discharge to include confirmed follow-up arrangements (not just instructions), clear communication to the next prescriber, and risk escalation routes when follow-up cannot be secured within the countyâs safety window.
Design principles that make discharge continuity real
High-performing counties standardize three elements: (1) a single âMAT continuity ownerâ per discharge, (2) a minimum bridge-supply rule with pharmacy confirmation, and (3) a verified appointment or warm handoff that can be audited. These are operational controls, not aspirational coordination.
Operational Example 1: Inpatient MAT continuity checklist with named ownership
What happens in day-to-day delivery. On admission, the inpatient nurse or pharmacist triggers a MAT continuity checklist: current dose verified (including last fill/administration), prescriber contact confirmed, and inpatient orders entered with a documented rationale. A designated discharge continuity owner (often a care coordinator) tracks tasks through discharge day.
Why the practice exists (failure mode it addresses). The key failure mode is ambiguity: nobody owns verification, nobody owns pharmacy coordination, and MAT becomes âsomeone elseâs responsibility.â A checklist plus named ownership prevents silent omissions and ensures the same steps happen regardless of unit or clinician.
What goes wrong if it is absent. Without a structured process, dose verification may rely on patient recall, inpatient orders may be delayed, and discharge prescriptions can be incomplete or unfilled. The gap shows up as withdrawal, early self-discharge, relapse, or rapid ED return after discharge.
What observable outcome it produces. Counties can evidence reduced missed-dose incidents, fewer âleft before treatment completeâ events linked to withdrawal, and improved discharge documentation quality. Audit sampling shows consistent completion rates and clear responsibility trails.
Operational Example 2: Bridge-supply and pharmacy reliability protocol
What happens in day-to-day delivery. Before discharge, the continuity owner confirms (a) prescription is written to the correct formulation, (b) pharmacy stock is confirmed, (c) prior authorization needs are resolved or an interim plan is in place, and (d) the person has a bridge supply that covers the countyâs follow-up window (including weekends/holidays).
Why the practice exists (failure mode it addresses). Discharge failures often occur at the pharmacy counter: stock-outs, coverage delays, or incorrect scripts. A reliability protocol treats dispensing as part of clinical safety, not an administrative afterthought.
What goes wrong if it is absent. If a prescription cannot be filled same day, people may go without medication, use illicit opioids to manage withdrawal, or disengage from follow-up. The system then absorbs preventable crisis contacts and the patient experiences discharge as abandonment.
What observable outcome it produces. Observable indicators include higher same-day fill rates, fewer post-discharge medication-gap reports, reduced ED visits within 7 days for withdrawal-related complaints, and a defensible pharmacy verification record for review.
Operational Example 3: Verified warm handoff with âcannot-bookâ escalation
What happens in day-to-day delivery. Discharge planning includes a verified appointment: the receiving provider confirms date/time and the plan is documented in the discharge summary. If an appointment cannot be secured within the safety window, staff trigger an escalation route (alternate clinic slot, telehealth bridge, or county-authorized interim prescriber).
Why the practice exists (failure mode it addresses). The failure mode is the âreferral illusionââa referral is sent, but no appointment exists. Escalation prevents the system from mistaking administrative completion for clinical continuity.
What goes wrong if it is absent. People leave hospital with instructions but no real access. Follow-up delays become medication gaps, relapse risk rises, and the person may re-enter through ED or law enforcement contact. Providers face scrutiny because the pathway lacked a time-bound safety backstop.
What observable outcome it produces. Counties can measure appointment verification rates, time-to-first-follow-up, and successful handoff completion. Escalation logs show how often âcannot-bookâ occurs and what corrective actions reduce it over time.
How to monitor and improve discharge continuity
Counties should track: (1) percentage of discharges with verified follow-up within the safety window, (2) bridge-supply reliability, (3) 7- and 30-day ED returns linked to withdrawal/relapse, and (4) completeness of discharge summaries shared to receiving providers. Continuous improvement cycles should review ânear-missâ casesâwhere a gap was narrowly avoidedâto strengthen controls before a preventable overdose or readmission occurs.